Actively Recruiting
Prospective Coronary Heart Disease Cohort
Led by Shandong First Medical University · Updated on 2023-02-13
50000
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
Sponsors
S
Shandong First Medical University
Lead Sponsor
J
Jinan Central Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
To evaluate the biomarkers for the prognosis of coronary heart disease, patients with coronary heart disease will be recruited and followed up for at least 2 years.
CONDITIONS
Official Title
Prospective Coronary Heart Disease Cohort
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with coronary heart disease or have unexplained chest pain requiring coronary angiography
- Healthy individuals undergoing routine physical examination who are willing to sign informed consent
You will not qualify if you...
- Having malignant tumors, infectious diseases, or advanced liver diseases
- Unwilling to sign informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shandong First Medical University
Jinan, Shandong, China, 277500
Actively Recruiting
Research Team
R
Rong Huang, Dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here